Laser Treatment of Moderate to Severe Acne Vulgaris
NCT: NCT04466527 · TERMINATED
Brief Summary
The goal of this clinical trial is to learn if fractional ablative laser can treat active acne vulgaris in adults 18 to 40 years old with moderate to severe acne vulgaris. The main questions it aims to answer are: Does ablative fractional carbon dioxide treatment effectively treat moderate to severe active nodular acne vulgaris? Does ablative fractional carbon dioxide treatment effectively treat moderate to severe active nodular acne vulgaris over a short time frame? Is non-selective laser useful in treating inflammatory skin disease? How does the microbiome change after laser treatment? Participants will... * Receive up to 3 laser treatments * Attend a baseline visit and follow-up visits post-treatment where participants will receive a clinical assessment, facial swab, and facial-imaging
Frequently Asked Questions
What is Laser Treatment of Moderate to Severe Acne Vulgaris?
Laser Treatment of Moderate to Severe Acne Vulgaris is a clinical trial registered under NCT04466527. Current status: TERMINATED.
What is the status of NCT04466527?
The current status of NCT04466527 (Laser Treatment of Moderate to Severe Acne Vulgaris) is: TERMINATED.
When did Laser Treatment of Moderate to Severe Acne Vulgaris start?
Laser Treatment of Moderate to Severe Acne Vulgaris started on 2020-11-09.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.